Cumberland Infirmary is a hospital in Carlisle, Cumbria, England. It is managed by the North Cumbria Integrated Care NHS Foundation Trust.

During the past decade, Cumberland Infirmary conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cumberland Infirmary" #1 sponsor was "Medical Research Council" with 4 trials, followed by "Institute of Cancer Research, United Kingdom" with 3 trials sponsored, "University College, London" with 3 trials sponsored, "Cancer Research UK" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cumberland Infirmary" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Aalborg University Hospital" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Action Medical Research" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Cumberland Infirmary" are "Breast Cancer" (6 trials), "Colorectal Cancer" (4 trials), "Prostate Cancer" (3 trials), "Fallopian Tube Cancer" (2 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "Cumberland Infirmary" in a lesser frequency.

Most popular intervention types in "Cumberland Infirmary" are "Drug" (21 trials), "Procedure" (7 trials), "Radiation" (6 trials), "Biological" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (4 trials), "radiation therapy" (4 trials), "adjuvant therapy" (3 trials), "cisplatin" (3 trials) and "quality-of-life assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Cumberland Infirmary" are 20 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Cumberland Infirmary". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Cumberland Infirmary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cumberland Infirmary, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".